Rongoā
Summary of Māori feedback on the inclusion of rongoā in the Therapeutic Products Bill (201-4) to the Ministry of Health.
Aug
2023
23
Aug
2023
3
Pharmac should not be criticised simply for being selective and slow about the medicines it funds
Pharmac is often criticised for not funding enough new medicines and for being too slow to determine which ones it will fund. However, being slow and focused is not proof of being too slow or too focused.
Jul
2023
19
Statement of Intent
The Statement of Intent (SOI) is published every three years. This document provides an overview of our strategic priorities for the next four years, as well as specific performance targets and measures.
Jun
2023
13
Therapeutic Products Bill
he purpose of the Therapeutic Products Bill is to protect, promote, and improve the health of all New Zealanders.
Apr
2023
17
Pharmacy Whakamahere: Understanding the pharmacy needs of our population – Summary of findings
During 2021 and 2022, the Pharmacy Team from Manatu Hauora - Ministry of Health and Te Whatu Ora – Health New Zealand consulted widely with consumer and whānau groups throughout Aotearoa.
The intent was to provide an opportunity for consumer groups to share their honest experiences of pharmacy with us along with suggestions for things that could be done better.
Apr
2023
12
Misuse of drugs
Cabinet material relating to:
Misuse of Drugs (Classification and Presumption of Supply) Commencement Order 2022 and the Misuse of Drugs (Classification and Presumption of Supply) Amendment Order 2022
Misuse of Drugs Amendment Regulations 2022 and Medicines Amendment Regulations (No 2) 2022.
Feb
2023
1
Investment to Increase Access to Medicines
Cabinet material related to the increase to the Combined Pharmaceutical Budget in the 2023/24 financial year.
Jan
2023
14
Impact of removing prescription co-payments on the use of costly health services: a pragmatic randomised controlled trial
Eliminating a small co-payment appears to have had a substantial effect on patients’ risk of being hospitalised.
Jan
2023
1
Therapeutic Products Bill: Approval for Introduction
Cabinet has agreed to repeal the Medicines Act 1981 (Medicines Act) and Dietary Supplements Regulations 1985 (made under the Food Act 2014) and replace them with new legislation that will regulate medicines, medical devices, active pharmaceutical ingredients, and natural health products (therapeutic products).
Dec
2022
6
How is the Societal Perspective Defined in Health Technology Assessment? Guidelines from Around the Globe
Considering the recent advancements in economic evaluation methods, it is timely to rethink the role of the societal perspective in HTA guidelines and adopt a more comprehensive perspective to include all costs and consequences of healthcare services.
Key issues
HEALTH SERVICES AND SYSTEMS
Covering developments in the provision, funding and organisation of health care services.
EQUITY
Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.
DRUGS, DEVICE AND DIAGNOSTICS
Covering prescription medicines and medical devices.
PUBLIC HEALTH
Focusing on efforts to promote health and prevent disease through social and economic interventions.
DIGITAL HEALTH
Exploring the potential digital transformation to provide a more connected and accessible health system.
TE TIRITI
Monitoring how the health reforms and the performance of the health sector uphold Te Tiriti obligations.